Immunocore Holdings Ltd share price logo

Immunocore Holdings Ltd

NASDAQ: IMCR

Small Cap

$28.41

-0.11

(-0.37%)

Live

as on

Immunocore Holdings Ltd Stock Performance

as on May 6, 2026 at 2:10 am IST

  • Day's Low

    Day's High

    $28.27
    $28.90
    downward going graph

    0.49%

    Downside

    1.72%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $27.44
    $40.71
    downward going graph

    3.41%

    Downside

    43.31%

    Upside

    downward going graph

Immunocore Holdings Ltd share price movements today

Previous Close
$28.52
Open
$28.73
Volume
90.0K
Day's Low - High
$28.27 - $28.90
52 Week Low - High
$27.44 - $40.71

Immunocore Holdings Ltd Historical Returns

1 Month Return
-7.49 %
3 Month Return
-7.76 %
1 Year Return
-6.89 %
3 Year Return
-52.33 %
5 Year Return
0 %

Immunocore Holdings Ltd Stock Fundamentals & Key Indicators

Check Immunocore Holdings Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.4B

EPS (TTM)

-0.9223

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

8.22%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-22.4M

Revenue (TTM)

400.0M

Profit Margin

-8.88%

Return On Equity TTM

-9.58%

Immunocore Holdings Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunocore Holdings Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Immunocore Holdings Ltd image
Immunocore Holdings Ltd
BUY$1.4BNANA-8.88%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.8B124.56%74.6712.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.3B100.99%27.732.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.0BNA118.865.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.5B47.01%17.1229.65%

Stock Returns calculator for Immunocore Holdings Ltd Stock including INR - Dollar returns

The Immunocore Holdings Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Immunocore Holdings Ltd investment value today

Current value as on today

₹1,04,840

Returns

₹4,840

(+4.84%)

Returns from Immunocore Holdings Ltd Stock

-₹7,248 (-7.25%)

Dollar Impact

₹12,088 (+12.09%)

Analyst Recommendation on Immunocore Holdings Ltd Stock

Based on 24 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 24 analysts, 91.67% of analysts recommend a 'BUY' rating for Immunocore Holdings Ltd. Average target price of $63.86

Immunocore Holdings Ltd Share Price Target

Get share price movements and forecasts by analysts on Immunocore Holdings Ltd.

What analysts predicted

55.51%UPSIDE

Target Price

$63.86

Current Price

$28.41

Analyzed by

24 Analysts

Target

$63.86

Immunocore Holdings Ltd target price $63.86, a slight upside of 55.51% compared to current price of $28.41. According to 24 analysts rating.

Immunocore Holdings Ltd Stock’s Investor Sentiment and Interest

Search interest for Immunocore Holdings Ltd Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:8% versus previous 30 day period

Immunocore Holdings Ltd Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
66
70
89
75
80
84
93
97
103
77
Gross Profit
64
70
89
73
79
83
93
96
103
74
Operating Income
-10
-13
-26
-16
-8
-19
-3
-14
-7
-14
EBITDA
-8
-19
-19
-5
10
-15
9
-6
4
-8
Interest Expense
1
1
3
3
3
6
3
3
3
3
Depreciation
1
0
1
0
1
1
0
0
0
0
Income Before Tax
1
-20
-24
-10
6
-24
6
-9
0
-11
Income Tax Expense
0
-4
0
1
-2
-1
1
0
0
10
Net Income
2
-19
-31
-11
8
-23
5
-10
0
-22
Net Profit Margin
3.70%
-28.12%
-34.66%
-15.41%
10.89%
-28.28%
5.35%
-10.51%
0.76%
-28.77%

Immunocore Holdings Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
25
25
29
33
40
35
175
249
247
297
Gross Profit
25
25
29
-97
-60
35
169
248
242
291
Operating Income
-39
-90
-93
-118
-86
-129
-42
-47
-56
-33
EBITDA
-36
-85
-86
-111
-82
-123
-38
-40
-38
0
Interest Expense
-
-
0
3
3
5
5
4
18
12
Depreciation
-
-
6
9
8
7
6
5
4
3
Income Before Tax
-38
-87
-88
-81
-87
-133
-33
-48
-42
-14
Income Tax Expense
9
21
-16
22
-13
0
9
-4
-1
12
Net Income
-35
-88
-90
-136
-99
-177
-52
-55
-40
-26
Net Profit Margin
-140.50%
-343.13%
-302.82%
-404.89%
-246.04%
-493.45%
-30.13%
-22.17%
-16.45%
-8.88%

Immunocore Holdings Ltd Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-15
-24
-11
8
-23
5
-10
0
-30
Operating Cash Flow
-13
-4
23
21
-13
0
25
-4
-32
Investing Cash Flow
0
0
-350
0
-3
9
-30
5
0
Financing Cash Flow
6
396
0
0
-51
2
3
1
4
Change in Cash
-1
390
-327
32
-82
21
11
10
-30

Immunocore Holdings Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-65
-71
-103
-74
-180
-52
-34
-51
-26
Operating Cash Flow
-81
-16
-101
-60
-143
-49
2
26
-7
Investing Cash Flow
-12
58
-4
0
-1
-2
-4
-355
-12
Financing Cash Flow
25
0
55
115
288
145
27
343
9
Change in Cash
-69
41
-50
55
144
81
31
13
8

Global Institutional Holdings in Immunocore Holdings Ltd

Funds
Holdings
Trails Edge Capital Partners, LP
1.34%
FMR Inc
8.93%
Citigroup Inc
1.26%
Kynam Capital Management, LP
1.68%
T. Rowe Price Associates, Inc.
2.01%
See all

Insights on Immunocore Holdings Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 17.5% return, outperforming this stock by 24.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, IMMUNOCORE HOLDINGS PLC-ADR has experienced a drawdown of -52.3%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 45.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 785.0K → -22.27M (in $), with an average decrease of 2937.9% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 103.69M → 77.42M (in $), with an average decrease of 25.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, IMCR stock has moved down by -7.5%

About Immunocore Holdings Ltd

Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally. The company offers KIMMTRAK for the treatment of unresectable or metastatic uveal melanoma. It also develops oncology programs, including tebentafusp which is in Phase 3 clinical trial for the treatment of advanced cutaneous melanoma and adjuvant uveal melanoma; brenetafusp which is in Phase 3 clinical trial for the treatment of first-line advanced cutaneous melanoma and in Phase 1/2 clinical trial for the treatment of various tumor types; IMC-R117C which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors, such as colorectal cancer; and IMC-P115C which is in Phase 1 clinical trial for patients with tumors that express PRAME. In addition, the company is involved in the development of IMC-M113V which is in Phase 1 clinical trial for a potential functional cure of human immunodeficiency virus; and IMC-I109V which is in Phase 1 clinical trial for a potential functional cure of hepatitis B virus. Further, it develops IMC-S118AI which is in pre-investigation stage for the treatment of type 1 diabetes; and IMC-U120AI which is in pre-investigation stage for the treatment of atopic dermatitis. The company was founded in 1999 and is headquartered in Abingdon, the United Kingdom.
OrganisationImmunocore Holdings Ltd
Headquarters92 Park Drive, Abingdon, United Kingdom, OX14 4RY
IndustryBiotechnology
CEODr. Bahija Jallal Ph.D.
E-voting on sharesClick here to vote

Key Management of Immunocore Holdings Ltd

Name

Title

Mr. John Goll III

SVP, Finance & Chief Accounting Officer

Ms. Annelise Vuidepot Ph.D.

Senior VP, CTO and Research & UK Site Lead

Ms. Elizabeth Varki Jobes Esq., J.D.

Chief Compliance Officer

Mr. Sébastien Desprez

Vice President of Communications

Dr. Bahija Jallal Ph.D.

CEO & Executive Director

Ms. Tina St. Leger

Executive VP & Chief Human Resources Officer

Mr. John Trainer M.B.A.

SVP & Chief Operating Officer

Mr. Sean D. Buckley

VP & Chief Information Officer

Ms. Lily Margaret Hepworth

Executive VP, General Counsel & Company Secretary

Mr. Travis Alan Coy M.B.A.

CFO, Executive VP & Head of Corporate Development

FAQs

What is Immunocore Holdings Ltd share price today?

Immunocore Holdings Ltd share price today is $28.41 as on . Immunocore Holdings Ltd share today touched a day high of $28.9 and a low of $28.27.

What is the 52 week high and 52 week low for Immunocore Holdings Ltd share?

Immunocore Holdings Ltd share touched a 52 week high of $40.71 on and a 52 week low of $27.44 on . Immunocore Holdings Ltd stock price today i.e. is trending at $28.41,which is 30.22% down from its 52 week high and 3.53% up from its 52 week low.

What is Immunocore Holdings Ltd's market capitalisation today?

Immunocore Holdings Ltd market capitalisation is $0.00T as on .

How to invest in Immunocore Holdings Ltd Stock (IMCR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunocore Holdings Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunocore Holdings Ltd Shares that will get you 0.0528 shares as per Immunocore Holdings Ltd share price of $28.41 per share as on May 5, 2026 at 8:40 pm IST.

What is the minimum amount required to buy Immunocore Holdings Ltd Stock (IMCR) from India?

Indian investors can start investing in Immunocore Holdings Ltd (IMCR) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Immunocore Holdings Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunocore Holdings Ltd share’s latest price of $28.41 as on May 5, 2026 at 8:40 pm IST, you will get 0.3520 shares of Immunocore Holdings Ltd. Learn more about fractional shares .